Loading...

New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness

Atrial fibrillation (AF) continues to be a leading cause of cerebrovascular morbidity and mortality resulting from cardioembolic stroke. Oral anticoagulation therapy has been shown to decrease the incidence of cardioembolic stroke in patients with AF by more than 50%. Appropriate use of anticoagulat...

Full description

Saved in:
Bibliographic Details
Main Authors: Mani, Helen, Lindhoff-Last, Edelgard
Format: Artigo
Language:Inglês
Published: Dove Medical Press 2014
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4069048/
https://ncbi.nlm.nih.gov/pubmed/24970997
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S45644
Tags: Add Tag
No Tags, Be the first to tag this record!